Artal Group’s Bausch Health BHC Stock Holding History

Artal Group’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-125,000	Closed	-$10.8M	–	84
2013 Q2	$10.8M	Buy	+125,000	New	+$9.85M	0.34%	43

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BWA

Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Artal Group's BHC Position: Q3 2013 in Review

Artal Group sold out of Bausch Health (BHC) in Q3 2013, closing a stake of 125,000 shares — an estimated $10.8M sold.

Artal Group first reported a position in BHC in Q2 2013 and held it in 1 quarter. The position peaked at $10.8M in Q2 2013. 368 funds tracked by Wall St. Rank hold BHC as of Q3 2013.

Artal Group reported no remaining Bausch Health position as of Q3 2013 after selling out during the quarter.
Artal Group sold 125,000 Bausch Health shares in Q3 2013, an estimated $10.8M.
Artal Group first reported a position in Bausch Health in Q2 2013 and held it in 1 quarter.
Artal Group's Bausch Health position peaked at $10.8M in Q2 2013.
368 funds tracked by Wall St. Rank held Bausch Health as of Q3 2013.

Based on Artal Group's 13F filing for Q3 2013, filed 14 Nov 2013.